The Response of Diabetic Retinopathy to 41 Months of Multiple Insulin Injections, Insulin Pumps, and Conventional Insulin Therapy

Archives of Ophthalmology

Volumn 106, Issue 9, 1988, Pages 1242-1246

  Brinchmann Hansen, Olaf ^a   Dahl Jørgensen, Knut ^b   Hanssen, Kristian F ^c   Sandvik, Leiv ^d  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b Pediatric Department   (Norway)

^c Medical Department B   (Norway)

^d AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

CLINICAL ARTICLE; DIABETES MELLITUS; DIABETIC RETINOPATHY; HUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; ANEURYSM; BLOOD GLUCOSE; CLINICAL TRIALS; DIABETIC RETINOPATHY; EXUDATES AND TRANSUDATES; FLUORESCEIN ANGIOGRAPHY; HEMOGLOBIN A; HUMAN; INJECTIONS; INSULIN; INSULIN INFUSION SYSTEMS; RETINAL HEMORRHAGE; RETINAL VESSELS; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0023706792     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archopht.1988.01060140402041     Document Type: Article

References (24)

1. Lauritzen T, Frost-Larsen K, Larsen H-W, et al: Effect of one year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics. Lancet 1983;1:200-204.
2. The Kroc Collaborative Study Group: Blood glucose control and the evolution of diabetic retinopathy and albuminuria. N Engl J Med 1984;311:365-372.
3. Van Ballegooie E, Hooymans JMM, Timmerman Z, et al: Rapid deterioration of diabetic retinopathy during treatment with continuous subcutaneous insulin infusion. Diabetes Care 1984;7:236-242.
4. Brinchmann-Hansen O, Dahl-Jørgensen K, Hanssen KF, et al: Effects of intensified insulin treatment on various lesions of diabetic retinopathy. Am J Ophthalmol 1985;100:644-653.
5. Dahl-Jørgensen K, Brinchmann-Hansen O, Hanssen KF, et al: Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: The Oslo study. Br Med J Clin Res 1985;290:811-815.
6. Dahl-Jørgensen K, Brinchmann-Hansen O, Hanssen KF, et al: Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: The Oslo study. Br Med J Clin Res 1986;293:1195-1199.
7. Dahl-Jørgensen K, Larsen AE: HbA1 determination by agar gel electrophoresis after elimination of labile HbA1: A comparison with ion-exchange chromatography. Scand J Clin Lab Invest 1982;42:27-33.
8. Tamborlane WV, Puklin JE, Bergman M, et al: Long-term improvement of metabolic control with the insulin pump does not reverse diabetic microangiopathy. Diabetes Care 1982;5(suppl 1):58-64.
9. Lauritzen T, Frost-Larsen K, Larsen H-W, et al: Two years' experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy. Diabetes 1985;34(suppl 3):74-79.
10. The Kroc Collaborative Study Group: The Kroc Study patients at two years: A report on further retinal changes, abstracted. Diabetes 1985;34(suppl):39A.
11. Job D, Eschwege E, Guyot-Argenton C, et al: Effect of multiple daily insulin injections on the course of diabetic retinopathy. Diabetes 1976;25:463-469.
12. Friberg TR, Rosenstock J, Sanborn G, et al: The effect of long-term near normal glycemic control on mild diabetic retinopathy. Ophthalmology 1985;92:1051-1058.
13. Canny CLB, Kohner EM, Trautman J, et al for The Kroc Collaborative Study Group: Comparision of Stereofundus photographs in patients with insulin-dependent diabetes during conventional insulin treatment or continuous subcutaneous insulin infusion. Diabetes 1985;34(suppl 3):50-55.
14. Hanssen KF, Dahl-Jørgensen K, Lauritzen T, et al: Diabetic control and microvascular complications: The near-normoglycaemic experience. Diabetologia 1986;29:677-684.
15. Dornan T, Mann JI, Turner R: Factors protective against retinopathy in insulin-dependent diabetics free of retinopathy for 30 years. Br Med J Clin Res 1982;285:1073-1077.
16. Klein R, Klein BEK, Moss SE, et al: The Wisconsin epidemiologic study of diabetic retinopathy: II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102:520-532.
17. Knuiman MW, Welborn TA, McCann VJ, et al: Prevalence of diabetic complications in relation to risk factors. Diabetes 1986;35:1332-1339.
18. Kohner EM, Dollery CT: The rate of formation and disappearance of microaneurysms in diabetic retinopathy. Eur J Clin Invest 1970;1:167-171.
19. Kohner EM, Sleightholm M: The Kroc Collaborative Study Group: Does microaneurysm count reflect severity of early diabetic retinopathy? Ophthalmology 1986;93:586-589.
20. Kohner EM, Dollery CT, Bulpitt CJ: Cotton-wool spots in diabetic retinopathy. Diabetes 1969;18:691-704.
21. Roy MS, Rick ME, Higgings KE, et al: Retinal cotton-wool spots: An early finding in diabetic retinopathy? Br J Ophthalmol 1986;70:772-778.
22. Esmann V, Lundbæk K, Madsen PH: Types of exudates in diabetic retinopathy. Acta Med Scand 1963;174:375-384.
23. The DCCT Research Group: Diabetes Control and Complications Trial (DCCT): Results of feasibility study. Diabetes Care 1987;10:1-19.
24. Brinchmann-Hansen O, Dahl-Jørgensen K, Hanssen KF, et al: Effects of intensified insulin treatment on retinal vessels in diabetic patients. Br J Ophthalmol, 1988;72:666-673.